IL114852A - Pharmaceutically stable preparation of oxaliplatinum - Google Patents

Pharmaceutically stable preparation of oxaliplatinum

Info

Publication number: IL114852A
Authority: IL; Israel
Prior art keywords: oxaliplatinum; pct; pharmaceutically stable; stable preparation; preparation
Prior art date: 1994-08-08

Application number

IL11485295A

Other languages

English (en)

Other versions

IL114852A0 (en

Inventor

Rolland-Yves Mauvernay

Houssam Ibrahim

Original Assignee

Debiopharm Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-08

Filing date

1995-08-07

Publication date

2000-02-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50845249&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL114852(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-08-07 Application filed by Debiopharm Sa filed Critical Debiopharm Sa

1995-12-08 Publication of IL114852A0 publication Critical patent/IL114852A0/xx

2000-02-29 Publication of IL114852A publication Critical patent/IL114852A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IL11485295A 1994-08-08 1995-08-07 Pharmaceutically stable preparation of oxaliplatinum IL114852A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CH246294		1994-08-08

Publications (2)

Publication Number	Publication Date
IL114852A0 IL114852A0 (en)	1995-12-08
IL114852A true IL114852A (en)	2000-02-29

Family

ID=50845249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL11485295A IL114852A (en)	1994-08-08	1995-08-07	Pharmaceutically stable preparation of oxaliplatinum

Country Status (17)

Country	Link
US (1)	US5716988A (xx)
EP (1)	EP0774963B1 (xx)
JP (1)	JP3547755B2 (xx)
KR (1)	KR100365171B1 (xx)
CN (1)	CN1138541C (xx)
AT (1)	ATE197249T1 (xx)
AU (2)	AU2989695A (xx)
BR (1)	BR9508554A (xx)
CA (1)	CA2196922C (xx)
CZ (1)	CZ286714B6 (xx)
DE (1)	DE69519300T2 (xx)
DK (1)	DK0774963T3 (xx)
ES (1)	ES2152412T3 (xx)
IL (1)	IL114852A (xx)
RU (1)	RU2148400C1 (xx)
UA (1)	UA42779C2 (xx)
WO (1)	WO1996004904A1 (xx)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5716988A (en)	1994-08-08	1998-02-10	Debiopharm S.A.	Pharmaceutically stable preparation of oxaliplatinum
GB9804013D0 (en) *	1998-02-25	1998-04-22	Sanofi Sa	Formulations
EP1121117B1 (fr) *	1998-10-14	2002-06-05	Debiopharm S.A.	Conditionnement d'une preparation d'oxaliplatine
GB9904386D0 (en) *	1999-02-25	1999-04-21	Pharmacia & Upjohn Spa	Antitumour synergistic composition
UA71985C2 (uk) *	1999-08-30	2005-01-17	Дебіофарм С.А.	Стабільний фармацевтичний препарат оксаліплатини для парентерального введення та спосіб його одержання
US7070796B1 (en)	1999-08-30	2006-07-04	Debiopharm S.A.	Pharmaceutically stable oxaliplatinum preparation for parenteral administration
US7012072B2 (en)	2000-12-12	2006-03-14	Debiopharm S.A.	Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
PT1368022E (pt) *	2001-03-02	2007-10-01	Debiopharm Sa	Utilização de um frasco em vidro que contém uma solução de oxaliplatina
US20040186172A1 (en) *	2001-07-02	2004-09-23	Houssam Ibrahim	Oxaliplatin active substance with a very low content of oxalic acid
TWI315982B (en)	2001-07-19	2009-10-21	Novartis Ag	Combinations comprising epothilones and pharmaceutical uses thereof
US6476068B1 (en)	2001-12-06	2002-11-05	Pharmacia Italia, S.P.A.	Platinum derivative pharmaceutical formulations
CA2388352A1 (en) *	2002-05-31	2003-11-30	Voiceage Corporation	A method and device for frequency-selective pitch enhancement of synthesized speed
US20040022842A1 (en) *	2002-06-03	2004-02-05	Mebiopharm Co., Ltd.	Liposome preparations containing oxaliplatin
CN101022790A (zh) *	2003-08-28	2007-08-22	梅恩医药有限公司	含有酸的奥沙利铂制剂
WO2005051966A1 (en)	2003-11-25	2005-06-09	Platco Technologies (Proprietary) Limited	Platinum(ii) complexes, preparation and use
CN100471493C (zh) *	2003-12-17	2009-03-25	梅比欧法姆股份有限公司	含有奥沙利铂的脂质体制剂
EA011573B1 (ru) *	2004-06-09	2009-04-28	Тайхо Фармасьютикал Ко., Лтд.	Препарат, потенцирующий противоопухолевый эффект, противоопухолевый препарат и способ лечения рака
WO2006024897A1 (en)	2004-09-01	2006-03-09	Platco Technologies (Proprietary) Limited	Preparation of platinum(ii) complexes
US20060063833A1 (en) *	2004-09-22	2006-03-23	Edgar Schridde	Ready-to-use oxaliplatin solutions
US20060063720A1 (en) *	2004-09-22	2006-03-23	Edgar Schridde	Oxaliplatin solution concentrate
DE102004052877B4 (de) *	2004-11-02	2008-06-19	Ebewe Pharma Ges.M.B.H. Nfg.Kg	Stabile wässrige Formulierungen eines Platin-Derivats
JP2006248978A (ja) *	2005-03-10	2006-09-21	Mebiopharm Co Ltd	新規なリポソーム製剤
WO2007029268A2 (en)	2005-09-05	2007-03-15	Dabur Pharma Limited	Stable oxaliplatin formulation
CA2640621A1 (en)	2006-01-30	2007-08-02	Platco Technologies (Proprietary) Limited	Preparation of platinum (ii) complexes
WO2007109184A2 (en) *	2006-03-16	2007-09-27	Bionumerik Pharmaceuticals, Inc.	Anti-cancer activity augmentation compounds and formulations and methods of use thereof
EP2026800A1 (en)	2006-05-09	2009-02-25	Novartis AG	Combination comprising an iron chelator and an anti-neoplastic agent and use thereof
EP2441464B1 (en) *	2007-01-18	2014-04-09	Merck Patent GmbH	Integrin ligands for use in treating colon cancer
US20090076139A1 (en) *	2007-09-19	2009-03-19	Protia, Llc	Deuterium-enriched oxalplatin
WO2009087660A1 (en) *	2007-11-12	2009-07-16	Intas Pharmaceuticals Limited	Stable oxaliplatin composition for parenteral administration
DK2249825T3 (en)	2008-03-14	2016-01-11	Bionumerik Pharmaceuticals Inc	Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions
CN102014891B (zh)	2008-03-14	2013-12-18	比奥纽默里克药物公司	增加癌症患者存活时间的化合物的组合物和使用方法
EP2481396A4 (en)	2009-09-21	2014-03-05	Jw Pharmaceutical Corp	OXALIPLATIN NANOPARTICLES AND MANUFACTURING METHOD THEREFOR
US20130096170A1 (en)	2011-10-14	2013-04-18	Hospira, Inc.	Methods of treating pediatric patients using dexmedetomidine
US8242158B1 (en)	2012-01-04	2012-08-14	Hospira, Inc.	Dexmedetomidine premix formulation
AU2013202575B1 (en) *	2012-01-04	2013-05-16	Hospira, Inc.	Dexmedetomidine premix formulation
JP5314790B1 (ja) *	2012-07-09	2013-10-16	東和薬品株式会社	オキサリプラチン含有医薬組成物
SG10201701063WA (en)	2012-08-10	2017-04-27	Taiho Pharmaceutical Co Ltd	Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same
PE20150964A1 (es)	2012-09-07	2015-07-25	Coherus Biosciences Inc	Formulaciones acuosas estables de adalimumab
CN103690494B (zh) *	2013-11-29	2015-04-15	杭州华东医药集团新药研究院有限公司	一种低杂质含有奥沙利铂的组合物及其制备方法
JP6336681B2 (ja)	2014-06-23	2018-06-06	プラコンセラピューティクスインコーポレイテッドＰｌａｃｏｎＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ．	白金化合物、組成物、及びそれらの使用
EP4335497A3 (en)	2015-07-07	2024-05-01	H. Lundbeck A/S	Pde9 inhibitor with imidazo pyrazinone backbone for treatment of peripheral diseases
CN104940151A (zh) *	2015-07-23	2015-09-30	青岛蓝盛洋医药生物科技有限责任公司	一种抗癌药物奥沙利铂冻干粉针剂组合物
US11229702B1 (en)	2015-10-28	2022-01-25	Coherus Biosciences, Inc.	High concentration formulations of adalimumab
US11071782B2 (en)	2016-04-20	2021-07-27	Coherus Biosciences, Inc.	Method of filling a container with no headspace
US10987353B2 (en)	2016-05-04	2021-04-27	The Wistar Institute Of Anatomy And Biology	Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and platinum-based antineoplastic drugs
CA3025586A1 (en)	2016-07-06	2018-01-11	Imara, Inc.	Pde9 inhibitors for treatment of peripheral diseases
MX2019014049A (es)	2017-05-26	2020-07-28	Imara Inc	Metodos de fabricacion y uso de inhibidores de pde9.
MX2020012636A (es)	2018-05-25	2021-01-29	Imara Inc	Formas de monohidrato y cristalinas de 6-[(3s,4s)-4-metil-1-(pirim idin-2- ilmetil)pirrolidin-3-il]-3-tetrahidropiran-4-il-7h-imidazo [1,5-a]pirazin-8- ona.
BR112021003686A2 (pt)	2018-08-31	2021-05-18	Imara Inc.	inibidores de pde9 para tratar doença falciforme

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6041077B2 (ja) *	1976-09-06	1985-09-13	喜徳喜谷	１，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
US4657927A (en) *	1978-05-04	1987-04-14	Research Corporation	Malonato platinum compounds
IL83380A (en) *	1987-07-30	1991-04-15	Teva Pharma	Stable aqueous cisplatin solutions
NL8901433A (nl) *	1989-06-06	1991-01-02	Pharmachemie Bv	Carboplatinpreparaat.
JPH04185601A (ja) *	1990-11-20	1992-07-02	Unitika Ltd	白金抗癌剤徐放性製剤
JP2673331B2 (ja)	1993-01-12	1997-11-05	田中貴金属工業株式会社	光学的に高純度なシス―オキザラート（トランス―１―１，２―シクロヘキサンジアミン）白金（▲ｉｉ▼）
WO1994012193A1 (fr) *	1992-11-24	1994-06-09	Debiopharm S.A.	Combinaison de cisplatine avec l'oxaliplatine
US5455270A (en) *	1993-08-11	1995-10-03	Bristol-Myers Squibb Co.	Stabilized solutions of platinum(II) antitumor agents
US5716988A (en)	1994-08-08	1998-02-10	Debiopharm S.A.	Pharmaceutically stable preparation of oxaliplatinum

1995
- 1995-08-07 US US08/776,240 patent/US5716988A/en not_active Expired - Lifetime
- 1995-08-07 KR KR1019970700780A patent/KR100365171B1/ko not_active Ceased
- 1995-08-07 BR BR9508554A patent/BR9508554A/pt not_active IP Right Cessation
- 1995-08-07 DE DE69519300T patent/DE69519300T2/de not_active Expired - Lifetime
- 1995-08-07 RU RU97104030A patent/RU2148400C1/ru not_active IP Right Cessation
- 1995-08-07 EP EP95925976A patent/EP0774963B1/fr not_active Expired - Lifetime
- 1995-08-07 AU AU29896/95A patent/AU2989695A/en not_active Abandoned
- 1995-08-07 ES ES95925976T patent/ES2152412T3/es not_active Expired - Lifetime
- 1995-08-07 WO PCT/IB1995/000614 patent/WO1996004904A1/fr not_active Ceased
- 1995-08-07 JP JP50715996A patent/JP3547755B2/ja not_active Expired - Lifetime
- 1995-08-07 AT AT95925976T patent/ATE197249T1/de not_active IP Right Cessation
- 1995-08-07 IL IL11485295A patent/IL114852A/xx not_active IP Right Cessation
- 1995-08-07 CN CNB951944436A patent/CN1138541C/zh not_active Expired - Lifetime
- 1995-08-07 UA UA97010366A patent/UA42779C2/uk unknown
- 1995-08-07 CZ CZ1997379A patent/CZ286714B6/cs not_active IP Right Cessation
- 1995-08-07 CA CA002196922A patent/CA2196922C/fr not_active Expired - Lifetime
- 1995-08-07 DK DK95925976T patent/DK0774963T3/da active
1999
- 1999-03-31 AU AU22524/99A patent/AU731981B2/en not_active Expired

Also Published As

Publication number	Publication date
US5716988A (en)	1998-02-10
CN1138541C (zh)	2004-02-18
AU731981B2 (en)	2001-04-12
AU2252499A (en)	2000-03-23
DK0774963T3 (da)	2001-01-29
EP0774963A1 (fr)	1997-05-28
CA2196922C (fr)	2004-06-01
CA2196922A1 (fr)	1996-02-22
BR9508554A (pt)	1997-11-25
JP3547755B2 (ja)	2004-07-28
DE69519300D1 (de)	2000-12-07
IL114852A0 (en)	1995-12-08
WO1996004904A1 (fr)	1996-02-22
KR100365171B1 (ko)	2003-02-19
CN1154654A (zh)	1997-07-16
DE69519300T2 (de)	2001-05-31
CZ286714B6 (en)	2000-06-14
JPH10508289A (ja)	1998-08-18
KR970704434A (ko)	1997-09-06
RU2148400C1 (ru)	2000-05-10
AU2989695A (en)	2000-03-07
UA42779C2 (uk)	2001-11-15
EP0774963B1 (fr)	2000-11-02
CZ37997A3 (en)	1997-06-11
ATE197249T1 (de)	2000-11-15
ES2152412T3 (es)	2001-02-01

Publication	Publication Date	Title
IL114852A (en)	2000-02-29	Pharmaceutically stable preparation of oxaliplatinum
PL325825A1 (en)	1998-08-03	Microemulsion for use as a carrier for administering active compounds
IL150326A (en)	2005-06-19	Pediatric formula
MXPA02008654A (es)	2004-09-06	Formulaciones de ranolazina de liberacion prolongada.
RU94040387A (ru)	1996-10-20	Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
NO20054324L (no)	2001-04-30	Anvendelse av ranolazin og minst ett pH-avhengig bindemiddel for fremstilling av ranolazinpreparater med depotvirkning
AU2001288460A1 (en)	2002-03-22	Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant
ZA912793B (en)	1992-12-30	Pharmaceutical formulations
MY114389A (en)	2002-10-31	Aqueous risperidone formulations
KR920702216A (ko)	1992-09-03	아세틸 d-카르니틴의 녹내장 치료에의 용도
SI1220670T1 (sl)	2006-12-31	Uporaba L-karnitina in njegovih alkanoil derivatov kot ozmotsko sredstvo za medicinske namene
WO2000041504A3 (en)	2000-11-09	Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides
NZ505821A (en)	2002-09-27	Pharmaceutical compositions of uridine triphosphate
AU1852597A (en)	1997-09-02	Multifunctional fat absorption and blood cholesterol reducing formulation containing chitosan and nicotinic acid
DK1673074T3 (da)	2007-05-07	Flydende præparat, indeholdende tobramycin
IL141232A0 (en)	2002-03-10	Use of camptothecin derivatives, with reduced gastrointestinal toxicity
NZ507407A (en)	2002-08-28	Stable mitoxantrone solutions
CA2015632A1 (en)	1990-11-10	Stable solutions of rebeccamycin analog and preparations thereof
NZ334949A (en)	2000-12-22	Stabilised pharmaceutical composition of quinupristine and dalfopristine with methanesulphonic acid or hydrochloric acid
ZA988820B (en)	1999-04-06	Use of delta-aminolaevulinic acid for the preparation of a topical medicament for the integral diagnosis and/or therapy of tumours in hollow organs
PL350413A1 (en)	2002-12-02	Pharmaceutical effervescent formulation containing metamizol
CA2120751A1 (en)	1993-04-15	Trimethoprim oral liquid
ES2125800A1 (es)	1999-03-01	Conjunto de infusion final.
MY104837A (en)	1994-06-30	Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
MX9708195A (es)	1998-07-31	Formulaciones para compuestos lipofilicos y uso de las mismas.

Legal Events

Date	Code	Title
2000-06-29	FF	Patent granted
2001-10-31	KB	Patent renewed
2005-11-20	KB	Patent renewed
2010-04-08	KB	Patent renewed
2013-07-31	KB	Patent renewed
2016-03-31	EXP	Patent expired